Hanmi Pharmaceutical is a global pharmaceutical manufacturing company headquartered in Seoul, South Korea, and established in 1973. The company develops and manufactures novel small and large molecule drugs and has comprehensive CDMO services from its state-of-the-art facilities in South Korea. Hanmi provides GMP testing and analysis, mRNA cap analog raw material supply, GMP manufacturing of drug substances for mRNA and pDNA therapeutics, and fill/finish. They are recognized as one of the top pharmaceutical R&D companies in Korea and sell over 200 products worldwide.